Bukwang Pharmaceutical to Strengthen OTC Marketing for Tasynol and Tabex Gel
"Strengthening Brand Competitiveness"
Bukwang Pharmaceutical is strengthening its over-the-counter (OTC) business by maintaining the pharmacy supply price of its antipyretic and analgesic "Tasynol," even as price increases for OTC drugs continue.
On August 3, Bukwang Pharmaceutical announced that it will reinforce the marketing of Tasynol, an acetaminophen-based antipyretic and analgesic, and Tabex Gel, a topical anti-inflammatory analgesic.
Although the retail price of some OTC drugs has recently risen, Bukwang Pharmaceutical has decided to keep the existing pharmacy supply price for Tasynol. The strategy is to use price competitiveness to reduce the burden on both pharmacies and consumers while increasing its market share.
During the COVID-19 pandemic, Bukwang Pharmaceutical continued the supply of acetaminophen by leveraging its own production facilities when a shortage occurred.
In addition, the company will expand marketing for Tabex Gel, its topical anti-inflammatory analgesic.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Bukwang Pharmaceutical plans to strengthen its nationwide pharmacy distribution network through a strategic sales partnership with Shinshin Pharmaceutical.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.